Clinical Trial Update: A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating iptacopan vs placebo for generalized myasthenia gravis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: RECRUITING